Randomized Double-Blind Placebo-Controlled Phase 2 Study of Bemarituzumab Combined with Modified Folfox6 (Mfolfox6) in First-Line (1L) Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (Fight).

AuthID
 P-00T-SFF
16
Author(s)
Wainberg, ZA
·
Enzinger, PC
·
Kang, YK
·
Yamaguchi, K
·
Qin, SK
·
Lee, KW
·
Oh, SC
·
Li, J
·
Turk, HM
·
Teixeira, AC
·
Cardellino, GG
·
Guardeno, R
·
Mitra, S
·
Yang, YS
·
Collins, H
·
Document Type
Abstract
Year published
2021
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 39, Issue: 3
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000636712800195
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service